Table 2.
Cardiovascular diseases and their risk factors associate with alternations of KP catabolites and enzymes
CVD and risk factors | Alternation of KP catabolites | Samples | KP enzymes | Samples | References |
---|---|---|---|---|---|
Atherosclerosis | AA↓, 3-HAA↓, KA↑ | Serum | IDO↑, IDO activity↑ | Plaque, serum | [36, 63] |
Myocardial infarction | KA↑, 3-HK↑, AA↑, 3-HAA↑ | Plasma | IDO↑ | Plasma | [64, 65] |
Coronary artery disease | Kyn↑, 3-HK↑ | Urine | IDO activity↑ | Urine | [66] |
Stroke | KA↑ | Serum | Active IDO1 | Serum | [67] |
Diabetes | KA↑, AA↑, XA↑, 3-HAA↑, Kyn↑, PLP↓ | Plasma, urine | IDO↑, KAT activity↑ | Plasma | [25, 50, 68–70] |
Hypertension | Kyn↑, KA↓ | Rat brain | Mutation in KAT I, KYNU mRNA↑, KYNU activity↓ | Brainstem | [71–73] |
Obesity | Kyn↑, KA↑, QA↑ | Serum | IDO1↑, KYNU↑, KMO↑, KAT III↑ | Omental adipose tissue | [74–77] |
Aging | Kyn↑, KA↑, 3-HK↑, AA↑, QA↑ | Rat brain | IDO1↑, TDO↓ | Brain striatum blood | [78–82] |
Smoking (nicotine) | KA↑, PLP↓ | Brain | N/A | [83] |
Refers to the main text for the expanded form of abbreviations